➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
McKinsey
Colorcon
AstraZeneca
Harvard Business School

Last Updated: October 22, 2021

DrugPatentWatch Database Preview

Patent: 6,201,105

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 6,201,105
Title: Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)
Abstract:Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
Inventor(s): Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA)
Assignee:
Application Number:09/233,461
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,201,105
Patent Claims:see list of patent claims

Details for Patent 6,201,105

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Immunex Corporation ENBREL etanercept For Injection 103795 1998-11-02 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept For Injection 103795 1999-05-27 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept Injection 103795 2004-09-27 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept Injection 103795 2007-02-01 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL MINI etanercept Injection 103795 2017-09-14 ⤷  Free Forever Trial 2009-09-05
Immunex Corporation ENBREL etanercept Injection 103795 ⤷  Free Forever Trial 2009-09-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 6,201,105

Country Patent Number Estimated Expiration
South Africa 907072 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 9406476 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 9319777 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 9103553 ⤷  Free Forever Trial
United States of America RE36755 ⤷  Free Forever Trial
United States of America 7459528 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Moodys
McKinsey
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.